On World Heart Day, the European Heart Network (EHN) calls on policy makers to show strong political will to improve cardiovascular health for all.

Dr Charmaine Griffiths, Chief Executive Officer of the British Heart Foundation, has been announced as President of the European Heart Network (EHN).

As of today, foods containing more than 2g/100g of industrially produced trans fatty acids are no longer allowed on the EU market. The removal of these trans fatty acids (TFAs) from the food supply is one of the most straightforward public health interventions in the EU.

Having reviewed latest evidence from scientific studies and high-quality, randomised controlled trials, the European Heart Network (EHN) published its revised paper on 'Early detection of cardiovascular disease'. 

More than 60 million people live with cardiovascular disease (CVD) in the EU, and close to 13 million new cases of CVD are diagnosed every year. Digital innovation in health can improve diagnosis, cardiovascular patients’ care, treatment and management, and lead to better human and economic outcomes. The COVID-19 pandemic has already demonstrated how accessible data is fundamental in the management of diseases.

Having reviewed the latest science, the European Heart Network (EHN) has adopted its position on front of pack nutrition labelling.

On 6 July, the ENVI committee will debate EU4Health. It is essential that the Programme responds to the needs of all people in the EU, including 60 million people living with CVD.

The European Heart Network (EHN) is delighted to announce that Birgit Beger will take over as Chief Executive Officer of the EHN on 1 August 2020.

The time for the EU to act is NOW!

Brussels, 25 June 2020. Today, the European Society of Cardiology (ESC) and the European Heart Network (EHN) launch “Fighting cardiovascular disease – a blueprint for EU action”, in a virtual meeting with the European Health Commissioner Stella Kyriakides and Members of the European Parliament.

As more data on COVID-19 patients become available, the disease appears to be particularly devastating for cardiovascular patients.